Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Children's Hospital of Philadelphia
University of Iowa
Information provided by (Responsible Party):
Spark Therapeutics, LLC
ClinicalTrials.gov Identifier:
NCT00999609
First received: October 21, 2009
Last updated: October 31, 2014
Last verified: October 2014